Literature DB >> 9309247

Human papillomavirus and other risk factors for cervical cancer.

F X Bosch1, N Muñoz, S de Sanjosé.   

Abstract

Cancer of the cervix is the second most common cancer in women after cancer of the breast, and the commonest in developing countries. In the last decade the etiology of cervical cancer has been unequivocally established--over 90% of the cases in all countries are related to infections to some strains of human papillomavirus (HPV). These infections are common in young age groups and resolve spontaneously in most instances. The typical HPV deoxyribonucleic acid (DNA) prevalence after the third decade lies between five and 15% of women. These findings form the basis of new strategies for screening and prevention of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9309247     DOI: 10.1016/s0753-3322(97)83542-1

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

1.  The analysis of human papillomavirus DNA in penile cancer tissue by in situ hybridization.

Authors:  Daiji Takamoto; Takashi Kawahara; Jun Kasuga; Takeshi Sasaki; Masahiro Yao; Yasushi Yumura; Hiroji Uemura
Journal:  Oncol Lett       Date:  2018-03-26       Impact factor: 2.967

2.  Efficacy in treatment of cervical HRHPV infection by combination of beta interferon, and herbal therapy in woman with different cervical lesions.

Authors:  Ermina Iljazović; Dzenita Ljuca; Ademir Sahimpasić; Silvija Avdić
Journal:  Bosn J Basic Med Sci       Date:  2006-11       Impact factor: 3.363

3.  Epidemiologic differentiation of diagnostic and screening populations for the assessment of cervical dysplasia using optical technologies.

Authors:  Bryan Pham; Helen Rhodes; Andrea Milbourne; Karen Adler-Storthz; Michele Follen; Michael E Scheurer
Journal:  Gend Med       Date:  2012-02

4.  Community-based participatory research (CBPR) in South Africa: engaging multiple constituents to shape the research question.

Authors:  Maghboeba Mosavel; Christian Simon; Debbie van Stade; Mara Buchbinder
Journal:  Soc Sci Med       Date:  2005-06-13       Impact factor: 4.634

Review 5.  Cancer in Jews: introduction and overview.

Authors:  Henry T Lynch; Wendy S Rubinstein; Gershon Y Locker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

6.  Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects.

Authors:  Chih Wen Tseng; Archana Monie; Cornelia Trimble; Ronald D Alvarez; Warner K Huh; Donald J Buchsbaum; J Michael Straughn; Mei-Cheng Wang; Hideo Yagita; Chien-Fu Hung; T-C Wu
Journal:  Vaccine       Date:  2008-07-01       Impact factor: 3.641

7.  Cervical cancer: a qualitative study on subjectivity, family, gender and health services.

Authors:  Blanca E Pelcastre Villafuerte; Laura L Tirado Gómez; Alejandro Mohar Betancourt; Malaquías López Cervantes
Journal:  Reprod Health       Date:  2007-03-01       Impact factor: 3.223

8.  Cervical cancer and pap smear awareness and utilization of pap smear test among Federal civil servants in North Central Nigeria.

Authors:  Hyacinth I Hyacinth; Oluwatoyosi A Adekeye; Joy N Ibeh; Tolulope Osoba
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

9.  Risk factors of cervical cancer among ethnic minorities in Yunnan Province, China: a case-control study.

Authors:  Min Zhao; Rong-Yan Gu; Song-Rui Ding; Lei Luo; Yue Jia; Chen-Xin Gao; Bin Chen; Xue-Bin Xu; Hong-Fen Chen
Journal:  Eur J Cancer Prev       Date:  2022-05-01       Impact factor: 2.164

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.